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The non-hydrolyzable S-linked azasugars, 1,6-a-mannosylthio- 
and 1,6-a-mannobiosylthioisofagomine, were synthesized and 
shown to bind with high affinity to a family 76 endo-1,6-a-
mannanase from Bacillus circulans. X-ray crystallography 
showed an atypical interaction of the isofagomine nitrogen with 
the catalytic acid/base. Molecular dynamics simulations reveal 
that the atypical binding results from sulfur perturbing the most 
stable form away from the nucleophile interaction preferred for 
the O-linked congener.   
1,6-a-Mannans are polysaccharides produced by fungi and 
bacteria.1, 2  In the fungal glycocalyx, such as that of the 
ascomycetes Saccharomyces cerevisiae and Candida albicans, 
they are present as part of the outer chain mannan,1 and are 
especially abundant in the latter organism, comprising up to 
40% of the mass of the cell wall.3 Within bacteria, 1,6-a-
mannans are found within the lipomannans and 
lipoarabinomannans of actinomycetes such as mycobacteria and 
corynebacteria.4 1,6-a-Mannans are degraded by endo-1,6-a-
mannanases, enzymes that cleave the polysaccharide chains 
into smaller fragments that are then further degraded by exo-
acting mannosidases. All known 1,6-a-mannanases fall into 
family 76 of the glycoside hydrolase (GH) classification 
scheme (www.cazy.org; www.cazypedia.org),5 which also 
includes putative fungal transglycosidases that have been 
proposed to act on protein glycosylphosphatidylinositol 
anchors.1, 6 The gut microbiota resident Bacteroides 
thetaiotaomicron produces GH76 endo-1,6-a-mannanases as 
cell surface and periplasmic enzymes that enable the 
depolymerisation of fungal cell wall mannan consumed in the 
human diet.7 GH family 76 enzymes are also deployed by the 
soil bacterium Bacillus circulans,8 possibly to enable nutrient 
acquisition from fungal or actinomycete cell wall fragments. 
We recently reported the first inhibitor of a GH family 76 
enzyme, ManIFG 1, which bound to the endo-1,6-a-mannanase 
from B. circulans (BcGH76) with modest affinity (KD 1.1 µM) 
(Fig. 1). This compound proved a useful mechanistic probe, and 
supplied evidence supporting a boat conformation at the 
enzyme-catalyzed transition state, and a OS2 → B2,5 → 
1
S5 
conformation pathway for GH family 76 catalysis.9 
 
Figure 1 Structures of S-linked and O-linked isofagomine-based inhibitors 
of Bacillus circulans endo-1,6-a-mannanase (BcGH76). 
	 The strategy used for the design of ManIFG 1 built upon a 
rich history of glycosidase inhibitor design.10 It is widely 
appreciated that exo-acting glycosidases are effectively 
inhibited by sugar-shaped heterocycle 'warheads' containing 
basic nitrogen in place of C1 or O5, e.g. isofagomine (IFG) or 
deoxymannojirimycin (DMJ). However, such simple 
monosaccharide-mimicking structures are frequently weak 
inhibitors of endo-acting glycosidases, which have multiple 
substrate binding subsites. By adding sugar residues to the 
warhead to mimic the natural substrate, effective inhibition of 
endoglycosidases can often be obtained. However, as such 
compounds have glycosidic linkages within, and are by virtue 
of the design process mimics of the substrate, the potential 
exists that they may themselves be substrates for their target 
enzymes. Typically, such concerns are limited for disaccharide-
based inhibitors, as disaccharides are rarely optimal substrates 
for endoglycosidases, but become more significant for 
trisaccharides and above. For example, cellotriose- and 
cellotetraose-like isofagomines were shown to be cleaved by 
cellulase Cel9A from Alicyclobacillus acidocaldarius.11 
Additionally, the natural product pseudo-tetrasaccharide 
inhibitor acarbose undergoes cleavage (and transglycosidation) 
by amylases.12  
 The natural product chitinase inhibitor allosamidin, which 
contains an allosamizoline inhibitor warhead, linked to N-
acetyl-b-allosamine residues, is a poor substrate for chitinases 
presumably by virtue of its mismatched sugar 
stereochemistry.13 An alternative design strategy to limit 
hydrolysis by the target enzyme is to attach sugar residues to 
the inhibitor warhead through non-hydrolyzable linkages. For 
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example, a C-glycosidic linkage was used within a non-
hydrolyzable epoxyalkyl C-glycoside inhibitor of an exo-
glycosidase,14 and alkylation of isofagomine on nitrogen by a 
sugar residue provided a weak inhibitor of isoamylase.15 In a 
related vein, a thioamide derivative of a chitooligosaccharide 
linked to the warhead NAG-thiazoline was not a substrate for 
chitinases that utilize neighboring group participation by virtue 
of the poorer nucleophilicity of the thionyl group relative to a 
carbonyl group.16 Given the similarity in size and bonding 
geometry of sulfur and oxygen, but the lower basicity of the 
former, an obvious alternative could be to use sulfur in place of 
oxygen in an S-glycosidic linkage. S-linked oligosaccharides 
have been widely employed as non-hydrolyzable mimics of 
glycosides, yet to our knowledge, no S-linked imino/azasugar 
endoglycosidase inhibitors have been reported. Here we report 
the synthesis and characterization of S-linked di- and 
trisaccharide azasugar inhibitors ManSIFG 2 and (ManS)2IFG 3 
targetting the endo-1,6-a-mannanase BcGH76.		
	 We have previously reported the preparation of a family of 
α-1,6-S-linked di-, tetra- and hexamannosides.17 The key 
element of this approach was the use of α-mannosyl 
thioacetates or isothiuronium bromides with defined anomeric 
stereochemistry as precursors of thiolate nucleophiles that can 
be used for substitution reactions of 6-deoxy-6-iodosugars. 
Accordingly, we undertook the synthesis of the protected 6-
iodo-isofagomine 5, from isofagomine tartrate. The advanced 
intermediate, alcohol 4,9 was iodinated using the procedure of 
Garegg and Samuelsson (I2, Ph3P, imidazole)
18 to afford iodide 
5 (Scheme 1a). Nucleophilic substitution proceeded in good 
yield upon treatment of 5 with mannosyl thiuronium bromide 
6
19 in the presence of Et3N,
20 affording disaccharide 7 (Scheme 
1b). Deprotection was achieved in two steps: Zemplén 
deacylation using NaOMe in MeOH afforded the hexaol 8; then 
removal of the Cbz group using TFA/anisole, followed by ion 
exchange chromatography, affording ManSIFG 2. Similarly, 
treatment of iodide 5 with disaccharide thioacetate 917 and 
Et2NH
21 afforded the trisaccharide 10 (Scheme 1c). 
Deprotection was achieved in a similar fashion affording 
(ManS)2IFG 3. 
	 The binding of ManSIFG 2 and (ManS)2IFG 3 to BcGH76 
was quantified by isothermal titration calorimetry. ManSIFG 
bound with KD = 0.90 ± 0.03 µM and (ManS)2IFG bound with 
KD = 24.7 ± 7.9 nM. The affinity of ManSIFG is similar to the 
O-linked variant, ManIFG 1 (KD = 1.1 µM), showing that the 
effect on affinity upon replacement of the glycosidic oxygen 
with sulfur	
	
Scheme 1 Synthesis of S-linked isofagomine inhibitors ManSIFG (2) and 
(Man)2SIFG (3). Tol = 4-methylbenzoyl. 
is minimal. (ManS)2IFG bound approximately 37-fold more 
tightly than ManSIFG, suggesting that extension of the 
inhibitor with an additional sugar residue enables capture of 
additional binding energy. 
 To illuminate the binding mode of compounds 2 and 3 with 
BcGH76, we soaked these inhibitors into crystals of the enzyme 
and solved their X-ray structures to resolutions of 1.69 and 1.46 
Å, respectively (Fig. 2a,b; Table S1). ManSIFG 2 bound in the 
–2/–1 subsites and (ManS)2IFG 3 bound in the –3/–2/–1 
subsites. As the interactions of the two inhibitors in the –2/–1 
subsites are essentially identical, the subsequent discussion will 
mainly focus on the higher affinity inhibitor (ManS)2IFG 3. 
Superficially, the three residues of this inhibitor occupy similar 
positions to the equivalent residues in a previously reported 
Michaelis complex in which a-mannopentaose was bound 
across the –4 to +1 subsites, and a complex with ManIFG 1, in 
which this inhibitor bound in the –2/–1 subsites.9 In the 
BcGH76-ManIFG complex the isofagomine moiety was in a 
B2,5 conformation and engaged in a close contact (2.8 Å) with 
the enzymatic nucleophile, Asp124, an interaction that is 
typical for IFG-type inhibitors of retaining glycosidases (see 
summary in Table S2). Interestingly, a longer (and presumably 
weaker) interaction of ManIFG with the acid/base Asp125 was 
also evident (N···O = 3.0 Å). Close inspection of the complexes 
with compounds 2 and 3 reveals that while the non-reducing 
end residues are positioned in the –3 and –2 subsites in 
essentially identical fashions as for the previously reported 
complexes with O-linked substrates and inhibitors, the IFG 
head-groups are positioned atypically, such that the nitrogen is 
engaged in a close contact with the acid/base Asp125 (N···O 
distance, 2: 2.7 Å, 3: 2.6 Å) and an N-H π interaction with 
Phe122 (for a summary of published complexes with IFG-type 
inhibitors see SI Table S2). In contrast with the complex of 
ManIFG with BcGH76, which was observed in a B2,5 
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conformation,9 in these complexes the isofagomine moiety is 
found in an undistorted 4C1 conformation.
22 We speculate that 
this close interaction involves a salt bridge with the protonated 
nitrogen of the inhibitor and the deprotonated Asp125 residue. 
Overlay of the binding mode of 1 and 2 or 3, reveals that the 
binding of the latter pair of inhibitors results in a rotation of the 
IFG head group about the S–C4(IFG) bond (Fig. 2c).  
 While the binding of compounds 2 and 3 are atypical for 
IFG-based inhibitors in that they do not engage with the 
enzymatic nucleophile, the coincidentally similar affinities of 
compounds 1 and 2 most likely arise from the inhibitors 
achieving equivalent ionic interactions with the enzymatic 
acid/base. The present complexes merit comparison with the 
complex of a cellobiose-like isofagomine with the inverting GH 
family 9 Cel9A from Alicyclobacillus acidocaldarius.11 In that 
case two molecules of the cellobiose-like isofagomine were 
observed in the complex, with one bound in the typical –2/–1 
mode, with the isofagomine nitrogen interacting with the 
general acid residue (Asp146). Remarkably, a second molecule 
of cello-IFG was bound in a reversed mode in the +2/+1 
subsites, with the IFG moiety bound in the +1 subsite and the 
nitrogen interacting with the general base residue (Glu515).  
 
Figure 2 Complexes of BcGH76 with (a) ManSIFG 2 (PDB: 5N0F) and (b) 
(ManS)2IFG 3 (PDB: 5M77) (c) Overlay of complexes of BcGH76 with 
(ManS)2IFG and ManIFG 1 (PDB: 4D4D).
9 Electron density meshes are 
σA-weighted 2F0 −  Fc contoured at 1σ (0.32 electrons per Å
3), assembled 
using CCP4mg.23 
 We sought to understand the underlying reasons for the 
atypical binding modes observed for inhibitors 2 and 3 using a 
computational approach (molecular dynamics).24 Initially, we 
explored the protonation state of the catalytic residues in the 
BcGH76–ManIFG and BcGH76–ManSIFG complexes. In both 
cases, the IFG moiety was assumed to be protonated on the 
basis of its high basicity; this has been directly observed 
experimentally in crystallographic studies of cellulase Cel5A.25 
Only models in which the ammonium-interacting carboxyl 
residue (the nucleophile and the acid/base, respectively) was 
deprotonated (Fig. 3; see also SI Fig. S2 and S3) could 
faithfully recapitulate the X-ray structures (for an overlay, see 
SI Fig. S4). Therefore, there is change of protonation state of 
the catalytic residues upon binding of ManSIFG in comparison 
to ManIFG, concurrent with the change of binding pose.  
 
Figure 3 Calculated complexes of BcGH76 with (a) ManIFG 1 and (b) 
ManSIFG 2.  
 Additional simulations in which O was replaced by S (and 
vice versa) in the corresponding complexes did not result in 
reversion of the binding mode of the ligand (i.e. replacement of 
O by S in BcGH76–ManIFG did not make the in silico complex 
evolve towards the “observed” BcGH76–ManSIFG, and vice 
versa). This suggests that the individual binding poses are 
stable states separated by a sizable energy barrier and that the 
two ligands achieve their respective binding modes directly 
during binding and not by inter-conversion between binding 
modes once bound. Further, for the BcGH76–ManIFG complex 
(Fig. 3a), the nucleophile-ammonium interaction appears to 
dominate, while the protonation state of the acid/base (D125) is 
less important, most likely because of the lack of an aglycon. 
By contrast, for the BcGH76–ManSIFG complex (Fig. 3b), in 
which the inhibitor ammonium group interacts with the 
deprotonated acid/base residue (see SI Fig. S5), the nucleophile 
(D124) must be protonated. In this case, both experimentally 
and throughout the MD simulation, a water molecule is 
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observed to interact with the protonated nucleophile that 
approximately occupies the position of the 3-OH residue in the 
ManIFG complex, thereby recapitulating this interaction. 
 S-linked oligosaccharides are useful substrate mimics that 
have been used to illuminate the active site details of a range of 
glycosidases;26 however, their use has not been without 
controversy. For example, recent work on a GH family 125 a-
mannosidase from Clostridium perfringens (CpGH125) 
revealed significant differences in the preferred conformations 
of O- and S-linked 1,6-α-mannobioses bound in the –1/+1 
subsites.27 Thus, while the S-linked 1,6-α-thiomannobiose was 
observed to bind in a 4C1 conformation, QM/MM MD predicted 
the 1,6-α-mannobiose to bind in an OS2 conformation to 
wildtype, and X-ray crystallography revealed it to bind in the 
same conformation to a disabled enzyme mutated at the 
catalytic acid residue. Another notable example is that of an 
active-site spanning Michaelis complex of a thiocellopentaoside 
bound to a Fusarium oxysporum cellulase, for which electron 
density for only three sugar residues could be observed in the 
X-ray structure.28 In both cases these anomalous observations 
likely result from the longer length of a C− S bond (1.89 vs 
1.48 Å for C− O) in a thioglycoside.27 These two prior studies, 
and the present work bring to attention the subtle yet significant 
limitations that sulfur-for-oxygen substitution within glycosides 
can have upon biological recognition by glycosidases.  
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1 The	non-hydrolyzable	S-linked	azasugar	1,6-a-mannobiosylthioisofagomine	effects	potent	inhibition	of	Bacillus	circulans	family	
76	endo-1,6-a-mannanase	through	an	atypical	interaction	with	the	acid/base	residue	of	the	enzyme.		
	
